Medicamen Biotech Ltd Annually Results

Gross Sales

179.31

140.87

115.45

112.72

125.5

Excise Duty

0

0

0

0

0

Net Sales

179.31

140.87

115.45

112.72

125.5

Other Operating Income

0

0

0

0

0

Other Income

2.33

2.46

1.72

0.75

1.94

Total Income

181.63

143.33

117.17

113.47

127.44

Total Expenditure

157.07

117

91.9

93.49

106.39

PBIDT

24.57

26.33

25.27

19.98

21.05

Interest

4.4

2.92

1.4

1.06

0.57

PBDT

20.17

23.41

23.87

18.91

20.48

Depreciation

7.09

6.37

5.77

2.52

2.5

Minority Interest Before NP

0

0

0

0

0

Tax

4.22

3.7

3.98

4.15

4.94

Deferred Tax

-0.64

-1.38

-0.78

0.12

-0.25

Reported Profit After Tax

9.49

14.73

14.9

12.13

13.29

Minority Interest After NP

-1.44

-0.12

0

0

0

Net Profit after Minority Interest

10.93

14.84

14.9

12.13

13.29

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

10.93

14.84

14.9

12.13

13.29

EPS (Unit Curr.)

7.5

11.82

12.19

9.93

10.94

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

10

10

10

10

5

Equity

12.65

12.65

12.22

12.22

12.22

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

13.7

18.69

21.88

17.72

16.77

PBDTM(%)

11.24

16.61

20.67

16.77

16.31

PATM(%)

5.29

10.45

12.9

10.76

10.58